
Phase 2 study tests AL001 brain-targeted lithium in bipolar I, aiming to cut toxicity and monitoring via advanced MRI/MRS imaging.

Phase 2 study tests AL001 brain-targeted lithium in bipolar I, aiming to cut toxicity and monitoring via advanced MRI/MRS imaging.

A psychiatrist reviews 2 Michael Finkel true-crime books, probing isolation, obsession, and morality.

Psychiatrists weigh autonomy, suffering, and safeguards in medical aid in dying, from the Dutch.

Chatbots feel empathic, raising psychiatry, ethics, and legal questions about consciousness and rights.

Guy Goodwin, MD, provides insights into COMP360 psilocybin and recent trial results, as well as psychedelics as a whole and their role in psychiatry.

Which supplements truly help athlete mental health? Look at this review on creatine, omega-3s, vitamin D, magnesium, and adaptogens, plus safety and dosing.

How proactive hospital psychiatry tackles social barriers, speeds older adults’ discharges, cuts burnout, and uses EHR/AI to improve outcomes.

Can ultra-low-carb eating ease schizophrenia symptoms? Evidence suggests metabolic gains and modest mood shifts, but no cure—here’s what studies show.

Learn how to spot catatonia quickly, use BFCRS screening, and safely treat with lorazepam or ECT while preventing complications.

A care partner shares how routines, early warning signs, supportive clinicians, and community help families manage bipolar I disorder and sustain hope.

Explore how psychiatrists can partner with medical teams to treat delirium, catatonia, and more—plus proactive models transforming hospital and ICU care.

Inside NYC’s historic nursing strike, explore moral distress, resentment, and patient anxiety—and what hospital psychiatrists need to navigate fallout.


Learn how physician assistants are playing a valuable role in mental health care.


AI romance chatbots turn loneliness into attachment—explore why they feel so real, and mental health risks unfolding now.

How cultural humility in psychiatry reframes global conflict, urging respect, diversity, and shared values amid escalating tensions.

Chronic community violence reshapes PTSD—often masking it as depression or ADHD. Learn why culturally responsive, trauma-informed diagnosis matters.

Unpack hikikomori’s global rise—and what it reveals about psychiatry’s diagnostic limits.

A psychiatrist revisits Lifton’s Nazi Doctors to explore ‘doubling,’ moral injury, and what aging and war teach about ethics and burnout.

"A “Prior Auth” parasite dumps me on hold, sucks another hour from my life..."

See which “natural” supplements actually help anxiety, depression, sleep, and schizophrenia—and how to avoid unsafe, mislabeled products.

New evidence suggests age-adjusted eGFR cutoffs refine CKD risk, guiding safer lithium use and avoiding unnecessary kidney alarms.

Explore how Mardi Gras, Ramadan, and Chinese New Year converge to spark reflection, emotional change, and a call for unity through everyday kindness.

Remote QbCheck testing tracks ADHD treatment progress.

Dutch psychiatric euthanasia cases surge among young adults, sparking debate over irremediability, activism, and suicide contagion risks.

New phase 2 data show HLP004 boosts standard antidepressants for moderate-to-severe GAD.

New RCT shows DBT cuts suicidal crises and self-harm in borderline personality disorder more than SSRIs, though benefits fade after treatment.

Phase 2 trial finds BXCL501 eases methadone-taper opioid withdrawal, outperforming lofexidine with simpler dosing and fewer adverse effects.

How preventive psychiatry reframes war debates, weighing acute risk, nuclear escalation, and why "watch and wait" can worsen global outcomes.